Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C38H50O6 |
| Molecular Weight | 602.8 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=C)[C@H](CC=C(C)C)C[C@]12C[C@H](CC=C(C)C)C(C)(C)[C@](CC=C(C)C)(C(=O)C(C(=O)C3=CC(O)=C(O)C=C3)=C1O)C2=O
InChI
InChIKey=QDKLRKZQSOQWJQ-AKAMJVKKSA-N
InChI=1S/C38H50O6/c1-22(2)11-13-27(25(7)8)20-37-21-28(15-12-23(3)4)36(9,10)38(35(37)44,18-17-24(5)6)34(43)31(33(37)42)32(41)26-14-16-29(39)30(40)19-26/h11-12,14,16-17,19,27-28,39-40,42H,7,13,15,18,20-21H2,1-6,8-10H3/t27-,28+,37+,38-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18470880Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/28688721 | https://www.ncbi.nlm.nih.gov/pubmed/20373302
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18470880
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/28688721 | https://www.ncbi.nlm.nih.gov/pubmed/20373302
Guttiferone E (GE) is a prenylated benzophenone derivative and a diastereoisomer of garcinol and a double bond isomer of xanthochymol, firstly isolated from Garcinia species plants. The Garcinia species plants, which are used in folk medicine across Southeast Asian countries, contain a rich source of secondary metabolites, including xanthones, flavonoids, benzophenones, triterpenes and, particularly, the polyprenylated benzophenones. Due to the structural side chains in the isomeric forms, in most cases, the isomers guttiferone E and xanthochymol have been considered as an inseparable mixture. By this reason, there is no information about biological activities of Guttiferone E as a single compound.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP1018 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23507522 |
|||
Target ID: WP3318 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18470880 |
|||
Target ID: CHEMBL3784 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20373302 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23507522
Leukemia cells (CCRF–CEM and HL-60), colon cancer cells (HCT116) and human glioblastoma multiforme U87MG cells were used for activity evaluation. Adherent cells were detached by treatment with 0.25% trypsin/EDTA (Invitrogen) and an aliquot of 1 x 10^4 cells was placed in each well of a 96-well cell culture plate (Thermo Scientific, Germany) in a total volume of 200 mkl. Cells were allowed to attach overnight and then were treated with different concentrations of compounds. For suspension cells, aliquots of 2 x 10^4 cells per well were seeded in 96-well-plates in a total volume of 100 mkl. The studied sample was immediately added in varying concentrations in an additional 100 mkl of culture medium to obtain a total volume of 200 mkl/well. After 24 h or 48 h, 20 mkl resazurin (Sigma–Aldrich, Germany) 0.01% w/v in ddH2O was added to each well and the plates were incubated at 37 ◦C for 4 h. Fluorescence was measured on an Infinite M2000 ProTM plate reader (Tecan, Germany) using an excitation wavelength of 544 nm and an emission wavelength of 590 nm.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
74F950KV9S
Created by
admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
|
PRIMARY | |||
|
147782-04-5
Created by
admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
|
PRIMARY | |||
|
76967922
Created by
admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD